Blockade of noradrenaline re-uptake sites improves accuracy and impulse control in rats performing a five-choice serial reaction time tasks (Q45339193)

13 December 2017

title

Blockade of noradrenaline re-uptake sites improves accuracy and impulse control in rats performing a five-choice serial reaction time tasks (English)

1 reference

13 December 2017

1 reference

Emma S J Robinson

1

1 reference

13 December 2017

publication date

30 July 2011

1 reference

13 December 2017

number of pages

10

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

13 December 2017

volume

219

1 reference

13 December 2017

issue

2

1 reference

13 December 2017

page(s)

303-312

1 reference

Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

The neuropsychopharmacology of fronto-executive function: monoaminergic modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Stimulants: Therapeutic actions in ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Molecular genetics of attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

21 January 2018

Neurobiology of ADHD.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

The neurobiology of attention deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Low-dose methylphenidate actions on tonic and phasic locus coeruleus discharge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Dopamine reuptake by norepinephrine neurons: exception or rule?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Neurochemical modulation of response inhibition and probabilistic learning in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Dimensional analysis of ADHD subtypes in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

The effects of serotonin and/or noradrenaline reuptake inhibitors on impulsive-like action assessed by the three-choice serial reaction time task: a simple and valid model of impulsive action using rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Pharmacological enhancement of memory and executive functioning in laboratory animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Methylphenidate-induced impulsivity: pharmacological antagonism by beta-adrenoreceptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Neuropharmacological modulation of cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Alpha adrenergic modulation on effects of norepinephrine transporter inhibitor reboxetine in five-choice serial reaction time task

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Selective depletion of cortical noradrenaline by anti-dopamine beta-hydroxylase-saporin impairs attentional function and enhances the effects of guanfacine in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Network reset: a simplified overarching theory of locus coeruleus noradrenaline function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Differential regulation of fronto-executive function by the monoamines and acetylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Lesions of the dorsal noradrenergic bundle impair attentional set-shifting in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Response requirement and increases in accuracy produced by stimulant drugs in a 5-choice serial reaction-time task in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulate, infralimbic and orbitofrontal cortex in the rat: differential effects on selectivity, impulsivity and compulsivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Methylphenidate and Atomoxetine Enhance Prefrontal Function Through α2-Adrenergic and Dopamine D1 Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: implications for theories of selective attention and arousal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: anterograde and retrograde tract-tracing studies in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2420-3

Distinct changes in cortical acetylcholine and noradrenaline efflux during contingent and noncontingent performance of a visual attentional task.

21 January 2018

1 reference

12 December 2020

Mechanism of action of agents used in attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Differential effects of psychomotor stimulants on attentional performance in rats: nicotine, amphetamine, caffeine and methylphenidate

1 reference

12 December 2020

Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex

1 reference

12 December 2020

Update on atomoxetine in the treatment of attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Regulation of extracellular dopamine by the norepinephrine transporter

1 reference

12 December 2020

10.1007/S00213-011-2420-3

Identifiers

DOI

1 reference

Dimensions Publication ID

13 December 2017

1022682193

0 references

1 reference